These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 3109803

  • 1. The interaction between sex hormone binding globulin and levonorgestrel released from Norplant, an implantable contraceptive.
    Affandi B, Cekan SZ, Boonkasemsanti W, Samil RS, Diczfalusy E.
    Contraception; 1987 Feb; 35(2):135-45. PubMed ID: 3109803
    [Abstract] [Full Text] [Related]

  • 2. Sex hormone binding globulin and free levonorgestrel index in the first week after insertion of Norplant implants.
    Alvarez F, Brache V, Tejada AS, Cochon L, Faundes A.
    Contraception; 1998 Oct; 58(4):211-4. PubMed ID: 9866001
    [Abstract] [Full Text] [Related]

  • 3. Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT implants or two covered rods (NORPLANT-2).
    Olsson SE, Odlind V, Johansson ED, Nordström ML.
    Contraception; 1987 Mar; 35(3):215-28. PubMed ID: 3111784
    [Abstract] [Full Text] [Related]

  • 4. Androgen levels in women using Norplant implants.
    Olsson SE, Odlind V, Johansson E.
    Contraception; 1986 Aug; 34(2):157-67. PubMed ID: 2946553
    [Abstract] [Full Text] [Related]

  • 5. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
    Boonkasemsanti W, Reinprayoon D, Pruksananonda K, Niruttisard S, Triratanachat S, Leepipatpaiboon S, Wannakrairot P.
    Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
    [Abstract] [Full Text] [Related]

  • 6. Endometrial angiogenic response in Norplant users.
    Subakir SB, Hadisaputra W, Handoyo AE, Affandi B.
    Hum Reprod; 1996 Oct; 11 Suppl 2():51-5. PubMed ID: 8982746
    [Abstract] [Full Text] [Related]

  • 7. The interaction between sex hormone binding globulin and levonorgestrel released from vaginal rings in women.
    Cekan SZ, Jia M, Landgren BM, Diczfalusy E.
    Contraception; 1985 Apr; 31(4):431-9. PubMed ID: 3924477
    [Abstract] [Full Text] [Related]

  • 8. Reduced endothelial cell migratory signal production by endometrial explants from women using Norplant contraception.
    Subakir SB, Hadisaputra W, Siregar B, Irawati D, Santoso DI, Cornain S, Affandi B.
    Hum Reprod; 1995 Oct; 10(10):2579-83. PubMed ID: 8567774
    [Abstract] [Full Text] [Related]

  • 9. Contraception with subdermal implants releasing levonorgestrel. A clinical and pharmacological study.
    Olsson SE.
    Acta Obstet Gynecol Scand Suppl; 1987 Oct; 142():1-45. PubMed ID: 3116821
    [Abstract] [Full Text] [Related]

  • 10. Immediate postpartum insertion of the norplant contraceptive device.
    Molland JR, Morehead DB, Baldwin DM, Castracane VD, Lasley B, Bergquist CA.
    Fertil Steril; 1996 Jul; 66(1):43-8. PubMed ID: 8752609
    [Abstract] [Full Text] [Related]

  • 11. First week drug concentrations in women with levonorgestrel rod or Norplant capsule implants.
    Sivin I, Lähteenmäki P, Mishell DR, Alvarez F, Diaz S, Ranta S, Grozinger C, Lacarra M, Brache V, Pavez M, Nash H, Stern J.
    Contraception; 1997 Nov; 56(5):317-21. PubMed ID: 9437561
    [Abstract] [Full Text] [Related]

  • 12. Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus.
    Dunson TR, Blumenthal PD, Alvarez F, Brache V, Cochon L, Dalberth B, Glover L, Remsburg R, Vu K, Katz D.
    Fertil Steril; 1998 Feb; 69(2):258-66. PubMed ID: 9496339
    [Abstract] [Full Text] [Related]

  • 13. The effects of reformulated 2-rod Norplant implant on hemostasis after three years.
    Viegas OA, Koh SC, Ratnam SS.
    Contraception; 1996 Oct; 54(4):219-28. PubMed ID: 8922875
    [Abstract] [Full Text] [Related]

  • 14. Effect of preovulatory insertion of Norplant implants over luteinizing hormone secretion and follicular development.
    Brache V, Alvarez F, Faundes A, Cochon L, Thevenin F.
    Fertil Steril; 1996 Jun; 65(6):1110-4. PubMed ID: 8641481
    [Abstract] [Full Text] [Related]

  • 15. Enhanced metabolism of levonorgestrel during phenytoin treatment in a woman with Norplant implants.
    Odlind V, Olsson SE.
    Contraception; 1986 Mar; 33(3):257-61. PubMed ID: 3087695
    [Abstract] [Full Text] [Related]

  • 16. [Effects of steroid contraceptive on serum levels of sex hormone binding globulin in women].
    Zhao XJ, Shao GX, Zhang J, Sang GW.
    Shengzhi Yu Biyun; 1992 Aug; 12(4):13-7. PubMed ID: 12286664
    [Abstract] [Full Text] [Related]

  • 17. Pregnancy after removal of Norplant implants contraceptive.
    Affandi B, Santoso SS, Djajadilaga, Hadisaputra W, Moeloek FA, Prihartono J, Lubis F, Samil RS.
    Contraception; 1987 Aug; 36(2):203-9. PubMed ID: 3123134
    [Abstract] [Full Text] [Related]

  • 18. Norplant-2 subdermal contraceptive system: experience in Taiwan.
    Lee TY, Yang YS, Tseng LH, Ko TM, Hsu MC, Chuang SM.
    J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
    [Abstract] [Full Text] [Related]

  • 19. Effects of levonorgestrel-releasing subdermal contraceptive implants on bone density and bone metabolism.
    Di X, Li Y, Zhang C, Jiang J, Gu S.
    Contraception; 1999 Sep; 60(3):161-6. PubMed ID: 10640160
    [Abstract] [Full Text] [Related]

  • 20. Levonorgestrel plasma levels during continuous administration with different models of subdermal implants.
    Alvarez F, Brache V, Faundes A, Johansson ED, Odlind V, Nash H.
    Contraception; 1983 Feb; 27(2):123-30. PubMed ID: 6406138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.